-
Anlotinib + Temozolomide: Glioma Treatment Study
22 Oct 2025 08:02 GMT
… in larger, randomized controlled trials to delineate the precise role … With gliomas continuing to challenge medical science, such advances reflect a … 15123-7
Tags: anlotinib temozolomide glioma treatment studyantiangiogenic properties in gliomabrain cancer …
-
<![CDATA[FDA Grants Fast Track Status to NBM-BMX for Metastatic Uveal Melanoma]]>
21 Oct 2025 21:28 GMT
… 47;2 NBM-BMX-UM trial (NCT07136181) will further evaluate … passed between the surgery and trial enrollment. No limit has … temozolomide will be given on days 1 to 5 of each treatment … .1
References
Novelwise Pharmaceutical receives US FDA fast track designation …
-
Nxera’s Partner Cancer Research UK Presents Data from Successfully Completed Phase 1 Clinical Trial of Cancer Immunotherapy Drug HTL0039732 at ESMO
21 Oct 2025 07:27 GMT
… develop and commercialize innovative medicines, including several launched products … with leading pharma and biotech companies. This pipeline … treatments for cancer. The Cancer Research UK Centre for Drug … it to market, including temozolomide for brain cancer, …
-
NovelWise Pharmaceutical Receives FDA Fast Track Designation for NBM-BMX in Metastatic Uveal Melanoma
16 Oct 2025 09:50 GMT
… treatment of metastatic uveal melanoma (mUM).
The FDA … review of investigational medicines intended to … program in combination with temozolomide (TMZ). Learnings … Pharmaceutical
NovelWise Pharmaceutical Corporation USA is a clinical-stage biotechnology …
-
Kerala RCC Blacklists Globela Pharma After Brain Cancer Drug Found in Wrong Packaging
12 Oct 2025 14:51 GMT
… dealings after uncovering that Temozolomide, a brain cancer drug, had been supplied … with poor prognosis and limited treatment options.
Etoposide is a podophyllotoxin … , “Every time a batch of medicine is received, the batch number …
-
Globela Pharma cancer drug mix-up: How Thiruvananthapuram's RCC averted a major crisis
09 Oct 2025 14:05 GMT
… pharmaceutical firm Globela Pharma after discovering that Temozolomide—a medicine … labelled for Etoposide, a drug intended for lung cancer. … had received the incorrect drug.
According to the … that officials representing the Drugs Controller of Kerala visited …
-
US FDA grants orphan drug designation to Precision NeuroMed’s investigational therapy for glioblastoma
09 Oct 2025 10:47 GMT
… clinical-stage biotechnology company pioneering advanced drug delivery technologies for … Food and Drug Administration (FDA) has granted Orphan Drug Designation for … treatment consists of maximal tumour resection followed by radiation therapy with temozolomide …
-
Thiruvananthapuram Regional Cancer Centre rejects reports of wrong drugs given to patients
09 Oct 2025 10:21 GMT
… consignment, and the distribution of medicines to patients was stopped.
None … , the pharmaceutical company Globelal Pharma Pvt. Ltd. has been supplying temozolomide 250 … the existing stock. As the drug (temozolomide) from a previous supply order …
-
<![CDATA[Cintredekin Besudotox Earns FDA Orphan Drug Designation in Glioblastoma]]>
08 Oct 2025 19:22 GMT
… resection and radiation therapy with temozolomide, which was approved in 2005 … NeuroMed Granted FDA Orphan Drug Designation by U.S. FDA for Treatment of Glioblastoma …
-
In a major mix-up, brain chemotherapy drug mistakenly given to lung cancer patients in Trivandrum RCC
09 Oct 2025 08:01 GMT
… concerns among patients and doctors.
The discrepancy was noticed … Examination by the State Drugs Controller confirmed the error … the sale of spurious medicines. Remaining stock has … involved Temozolomide 100 tablets, intended for brain cancer treatment. However …